• Publications
  • Influence
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.
List of participants (GOLD Scientific Committee): Nicholas Anthonisen, Winnipeg, Canada; William C. Bailey, Birmingham, US; Peter J. Barnes, London, UK; Tim Clark, London, UK; Leonardo Fabbri,Expand
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
The main goals of the updated document are to improve the quality of care provided to patients with COPD and to develop the project using a disease-oriented approach. Expand
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study
This worldwide study showed higher levels and more advanced staging of spirometrically confirmed COPD than have typically been reported and variations in disease prevalence-other factors also seem to be important. Expand
Global burden of COPD: risk factors, prevalence, and future trends
Advances in understanding of COPD are increased recognition of the importance of comorbid disease, identification of different COPD phenotypes, and understanding how factors other than lung function affect outcome in patients. Expand
Global burden of COPD: systematic review and meta-analysis
The aim of this study was to quantify the global prevalence of chronic obstructive pulmonary disease by means of a systematic review and random effects meta-analysis and population-based prevalence estimates published during the period 1990–2004. Expand
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
An aggressive smoking intervention program significantly reduces the age-related decline in FEV1 in middle-aged smokers with mild airways obstruction and use of an inhaled anticholinergic bronchodilator results in a relatively small improvement that appears to be reversed after the drug is discontinued. Expand
Validation of a standardized version of the Asthma Quality of Life Questionnaire.
The AQLQ(S) has strong measurement properties and is valid for measuring health-related quality of life in asthma and the choice of instrument should depend on the task at hand. Expand
Epidemiology and costs of chronic obstructive pulmonary disease
COPD is under-diagnosed not only in its early stages, but even when lung function is severely impaired, and the message that COPD is both preventable and treatable has yet to be fully understood by most healthcare providers. Expand